Rani Therapeutics Holdings RANI
NASDAQ RANI
$0.81 +0.02 (+1.89%)
As of: Oct 2, 2026 · 9:42 AM EDT

Rani Therapeutics Holdings (RANI) Share-based Compensation (2021 - 2026)

Updated

Rani Therapeutics Holdings (RANI) reported Share-based Compensation of $2.42 million for Q2 2026, down 26.4% from $3.29 million a year earlier but up 16.3% from the prior quarter.

Analysis

Rani Therapeutics Holdings (RANI) Share-based Compensation (2021 - 2026) Analysis & Trends

Over the twelve months ended Jun 30, 2026, Rani Therapeutics Holdings' Share-based Compensation came in at $9.09 million, down 40.4% year-over-year; for FY2025, it came in at $11.8 million, down 26.4% from FY2024.

  • Share-based Compensation has a four-year compound annual growth rate of -15.0% (FY2021 to FY2025).
  • By year, Share-based Compensation came in at $16.03 million in FY2024 (-15.7%), $19.01 million in FY2023 (+20.4%), $15.78 million in FY2022 (-30.2%) and $22.6 million in FY2021.
  • Five-year quarterly Share-based Compensation spans a low of $2.08 million in Q1 2026 and a high of $18.7 million in Q3 2021.
  • Year over year, Share-based Compensation has now declined in each of the last five quarters, with an average decline of 26.0% over the last eight quarters.
  • The high point for year-over-year Share-based Compensation in five years was Q1 2022 (growth of 541.3%); the low point was Q3 2022 (a decline of 76.5%).
  • Per Business Quant data, the three quarters before Q2 2026 came in at $2.08 million (Q1 2026), $2.24 million (Q4 2025) and $2.34 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Stock Comp. (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn 458.00 Mn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn 166.00 Mn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn 298.00 Mn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn -
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn -
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn 165.00 Mn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn 231.00 Mn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn 249.00 Mn
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn 170.20 Mn
10 Rani Therapeutics Holdings 147.86 Mn 156.61 Mn - 2.42 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 2.42 Mn
Mar 31, 2026 2.08 Mn
Dec 31, 2025 2.24 Mn
Sep 30, 2025 2.34 Mn
Jun 30, 2025 3.29 Mn
Mar 31, 2025 3.93 Mn
Dec 31, 2024 3.99 Mn
Sep 30, 2024 4.04 Mn
Jun 30, 2024 4.13 Mn
Mar 31, 2024 3.87 Mn
Dec 31, 2023 4.49 Mn
Sep 30, 2023 4.97 Mn
Jun 30, 2023 5.14 Mn
Mar 31, 2023 4.42 Mn
Dec 31, 2022 4.50 Mn
Sep 30, 2022 4.40 Mn
Jun 30, 2022 3.98 Mn
Mar 31, 2022 2.91 Mn
Dec 31, 2021 3.16 Mn
Sep 30, 2021 18.70 Mn
API Access

Rani Therapeutics Holdings Share-based Compensation API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=share-based-compensation&ticker=RANI&period=max&api_key=YOUR_API_KEY